Alligator Bioscience AB (publ) (STO:ATORX)

Alligator Bioscience AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.61	62.2	64.31	66.12	97.31	278.15
Cash & Short-Term Investments	16.61	62.2	64.31	66.12	97.31	278.15
Cash Growth	-50.98%	-3.28%	-2.73%	-32.05%	-65.02%	169.15%
Accounts Receivable	-	-	0.52	0	13.93	7.45
Other Receivables	3.54	5.77	4.93	9.34	4.54	8.86
Receivables	3.54	5.77	5.45	9.34	18.47	16.31
Prepaid Expenses	3.54	0.7	1.64	2.73	7.04	5.16
Other Current Assets	-	-	-	-	0	-
Total Current Assets	23.69	68.66	71.4	78.19	122.81	299.61
Property, Plant & Equipment	1.36	1.87	3.02	20.31	26.94	15.42
Other Intangible Assets	40.07	40.07	27.87	17.96	18.02	18.17
Other Long-Term Assets	-	-	2.06	1.99	1.82	0
Total Assets	65.12	110.6	104.34	118.45	169.58	333.2

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.04	4.58	3.95	21.27	13.34	9.37
Accrued Expenses	17.12	12.87	42.49	63.3	38.62	13.42
Short-Term Debt	-	8.34	137.24	-	-	-
Current Portion of Leases	8.79	9.21	10.1	8.58	8.5	6.23
Current Unearned Revenue	-	0.11	0.76	0.56	0.77	6.56
Other Current Liabilities	6.71	43.04	6.92	5.37	3.3	11.85
Total Current Liabilities	40.65	78.15	201.45	99.08	64.53	47.42
Long-Term Leases	21.14	25.6	33.48	7.52	16	3.51
Other Long-Term Liabilities	-0	-	-	-	0	-
Total Liabilities	61.79	103.74	234.93	106.6	80.53	50.93

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	125.62	8.76	0.61	42.17	88.61	88.23
Additional Paid-In Capital	1,213	1,301	1,147	1,055	911.9	911.83
Retained Earnings	-1,335	-1,303	-1,278	-1,086	-911.46	-717.79
Comprehensive Income & Other	0	-	-	-	-0	-
Shareholders' Equity	3.33	6.86	-130.59	11.86	89.05	282.27
Total Liabilities & Equity	65.12	110.6	104.34	118.45	169.58	333.2

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	29.93	43.15	180.81	16.1	24.5	9.74
Net Cash (Debt)	-13.31	19.05	-116.5	50.02	72.8	268.41
Net Cash Growth	-	-	-	-31.29%	-72.88%	194.09%
Net Cash Per Share	-0.04	0.69	-158.66	111.53	330.05	2993.33
Filing Date Shares Outstanding	628.11	43.81	0.76	0.66	0.22	0.22
Total Common Shares Outstanding	628.11	43.81	0.76	0.66	0.22	0.22
Working Capital	-16.96	-9.48	-130.06	-20.89	58.29	252.2
Book Value Per Share	0.01	0.16	-172.23	18.02	403.70	1279.66
Tangible Book Value	-36.74	-33.21	-158.45	-6.11	71.03	264.11
Tangible Book Value Per Share	-0.06	-0.76	-208.98	-9.28	322.02	1197.30
Machinery	-	1.81	34.83	34.83	32.37	31.93
Leasehold Improvements	-	-	-	-	-	3.07

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error